BWXT Announces Availability of FDA-Approved Indium In-111 Oxyquinoline Solution

 (LYNCHBURG, Va. – September 26, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT ITG Canada, Inc., having received approval from the U.S. Food and Drug Administration (FDA) on its abbreviated new drug application for its generic version of Indium In-111 Oxyquinoline Solution, is now making the product available for sale in […]

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.